Company News For Jan 31, 2020
Zacks Investment Research | Jan 30, 2020 10:41PM ET
- Shares of Miragen Therapeutics, Inc. (NASDAQ:MGEN) surged 20.7% after the company reported positive data from its continuing Phase 1 trial of cobomarsen in adult t-cell leukemia/lymphoma patients with residual disease.
- Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) gained 13.4% after the company announced collaboration with Beijing Advaccine Biotechnology for advancement of INO-4800 against the Coronavirus.
- Shares of Mondelez International, Inc. (NASDAQ:MDLZ) rose 7.8% after the company reported quarterly earnings of 61 cents per share, which beat the Zacks Consensus Estimate by a penny.
- Shares of Briggs & Stratton Corporation (NYSE:BGG) declined 21% after the company reported a quarterly loss of $0.20 per share against the Zacks Consensus Estimate of a loss of $0.11.
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.